Xilio Therapeutics, Inc.XLONASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank83
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-43.77M
↑ 27% vs avg
Percentile
P83
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-60.18M
Historical baseline
PeriodValueYoY Change
TTM$-43.77M+27.7%
2024$-60.58M+23.4%
2023$-79.13M+11.2%
2022$-89.15M-18.8%
2021$-75.04M-37.5%
2020$-54.56M-186.8%
2019$-19.03M-